Q3 2023 Holdings
Filed 2023-11-14 | 1 holdings | $37.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $1.0B | 10,719,555 | 19.9% |
| Legend Biotech Corp(LEGN) | COM | 52490G102 | $420.8M | 6,264,707 | 8.3% |
| Vaxcyte Inc(PCVX) | SPONSORED ADS | 92243G108 | $402.3M | 7,891,254 | 8.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $211.4M | 13,322,288 | 4.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $176.3M | 11,416,948 | 3.5% |
| Biogen Inc(BIIB) | SPONSORED ADR | 09062X103 | $137.0M | 532,892 | 2.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $130.1M | 5,676,067 | 2.6% |
| Aerovate Therapeutics Inc | COM | 008064107 | $112.1M | 8,263,982 | 2.2% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $103.5M | 6,940,000 | 2.1% |
| Verona Pharma PLC(VRNA) | COM | 925050106 | $103.0M | 6,317,990 | 2.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $99.6M | 7,236,454 | 2.0% |
| Wave Life Sciences LTD(WVE) | COM | Y95308105 | $98.9M | 17,202,009 | 2.0% |
| Geron Corp(GERN) | COM | 374163103 | $97.9M | 46,202,425 | 1.9% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $95.8M | 7,809,852 | 1.9% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $92.4M | 9,165,652 | 1.8% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $89.3M | 5,551,295 | 1.8% |
| Inhibrx Inc(INBXUSD) | SH | 45720L107 | $86.7M | 4,724,207 | 1.7% |
| Rxsight Inc(RXST) | COM | 78349D107 | $85.1M | 3,052,796 | 1.7% |
| Newamsterdam Pharma Co NV(NAMS) | ORD SHS | N62509109 | $83.3M | 9,000,000 | 1.7% |
| Evolent Health Inc(EVH) | COM | 30050B101 | $74.5M | 2,736,680 | 1.5% |
| Curevac NV | COM | N2451R105 | $72.4M | 10,604,344 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | CLASS A ORD SHS | 05464T104 | $69.9M | 1,000,000 | 1.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $62.6M | 6,416,147 | 1.2% |
| Acumen Pharmaceuticals Inc(ABOS) | COMMON STOCK | 00509G209 | $62.0M | 14,932,063 | 1.2% |
| Taysha Gene Therapies Inc(TSHA) | COM | 877619106 | $58.4M | 18,472,503 | 1.2% |
| GH Research PLC(GHRS) | SPONSORED ADR | G3855L106 | $56.2M | 5,587,333 | 1.1% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $53.7M | 4,691,178 | 1.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $53.0M | 4,163,211 | 1.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $51.5M | 11,609,704 | 1.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $48.4M | 4,417,259 | 1.0% |
| VOR Biopharma Inc | COM | 929033108 | $48.2M | 22,748,880 | 1.0% |
| Icosavax Inc | COM | 45114M109 | $46.2M | 5,963,565 | 0.9% |
| Acrivon Therapeutics Inc(ACRV) | COM | 004890109 | $46.0M | 4,810,508 | 0.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $42.1M | 1,977,901 | 0.8% |
| Pepgen Inc(PEPG) | COM | 713317105 | $41.3M | 8,131,952 | 0.8% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $40.9M | 6,416,998 | 0.8% |
| Cytek Biosciences Inc(CTKB)A | COM | 23285D109 | $37.6M | 6,809,404 | 100.0% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $36.6M | 1,239,000 | 0.7% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $35.8M | 9,459,678 | 0.7% |
| Eliem Therapeutics Inc(CLYM) | ADS | 28658R106 | $34.6M | 13,150,849 | 0.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $30.8M | 2,007,946 | 0.6% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $30.6M | 1,762,000 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $30.2M | 3,178,476 | 0.6% |
| Aclaris Therapeutics Inc(ACRS) | SPONSORED ADS | 00461U105 | $30.1M | 4,398,453 | 0.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $29.9M | 204,500 | 0.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $29.0M | 2,122,465 | 0.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM | 30233G209 | $26.9M | 3,370,506 | 0.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $20.8M | 1,483,697 | 0.4% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $17.1M | 6,718,483 | 0.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADR | 088786108 | $16.1M | 800,000 | 0.3% |